IV treatment may lower risk of dying from bacterial meningitis
ST. PAUL, Minn. – New research shows that an intravenous (IV) treatment may cut a person's risk of dying from bacterial meningitis. The research is published in the September 29, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. The treatment is called dexamethasone. "Using this treatment in people infected with meningitis has been under debate because in a few large studies it was shown to be ineffective," said study author Diederik van de Beek, MD, PhD, with the Academic Medical Center, University of Amsterdam in the Netherlands ...
Read the release